Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.453 USD | -1.11% | -0.74% | -68.97% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-68.97% | 14.6M | |
-1.85% | 89.87B | |
-1.05% | 37.57B | |
-11.04% | 32.75B | |
+61.85% | 26.47B | |
-20.73% | 14.25B | |
-6.29% | 12.99B | |
-11.42% | 11.93B | |
-47.67% | 10.84B | |
+5.99% | 9.11B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Transcript : RedHill Biopharma Ltd., Q3 2021 Earnings Call, Nov 30, 2021